GlassScriptPhysician profile
Cathy Q He
NPI 1205248069
$10,787.48
in general payments reported to CMS, 2019-2025
33 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,584 · 2020: $1,454 · 2021: $1,973 · 2022: $3,872 · 2023: $326 · 2024: $300 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $904.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,099.46 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $2,276.98 | 2019-2024 | Senza |
| Abbott Laboratories | $2,048.06 | 2019-2023 | Proclaim |
| Boston Scientific Corporation | $1,005.94 | 2019-2024 | |
| Medtronic USA, INC. | $635.76 | 2019-2020 | |
| Globus Medical, INC. | $255.14 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $220.16 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $187.38 | 2019-2021 | |
| Relievant Medsystems, INC. | $173.90 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $104.87 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $90.60 | 2020-2021 | |
| Mdd US Operations, LLC | $68.33 | 2019-2020 | |
| Almatica Pharma LLC | $59.69 | 2021 | |
| Spr Therapeutics, INC | $51.64 | 2021 | |
| Tersera Therapeutics LLC | $45.03 | 2020-2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $42.25 | 2021 | |
| Ethicon US, LLC | $37.16 | 2023 | Ethicon, Surgicel Nu-Knit |
| Redhill Biopharma INC. | $36.96 | 2020 | |
| Eisai INC. | $34.99 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $33.58 | 2021 | |
| Horizon Therapeutics Plc | $31.91 | 2019-2021 | |
| Flowonix Medical Incorporated | $27.85 | 2020 | |
| Painteq LLC | $27.76 | 2021 | |
| Amgen INC. | $27.47 | 2020 | |
| Electronic Waveform Lab, INC. | $27.36 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $23.73 | 2025 | |
| Stimwave Technologies Incorporated | $20.00 | 2020 | |
| Alexion Pharmaceuticals, INC. | $18.82 | 2019 | |
| Avanos Medical | $17.92 | 2024 | Generator |
| Bioventus LLC | $16.69 | 2020 | |
| Lilly USA, LLC | $15.38 | 2020 | |
| Fidia Pharma USA INC. | $12.60 | 2020 | |
| Biodelivery Sciences International, INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cathy He listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.